- Home
- CNSP vs PAVM Comparison
CNSP vs PAVM Comparison
Compare CNSP & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNSP
- PAVM
- Stock Information
- Founded
- CNSP 2017
- PAVM 2014
- Country
- CNSP United States
- PAVM United States
- Employees
- CNSP N/A
- PAVM N/A
- Industry
- CNSP Biotechnology: Pharmaceutical Preparations
- PAVM Medical/Dental Instruments
- Sector
- CNSP Health Care
- PAVM Health Care
- Exchange
- CNSP Nasdaq
- PAVM Nasdaq
- Market Cap
- CNSP 6.5M
- PAVM 6.7M
- IPO Year
- CNSP 2019
- PAVM 2016
- Fundamental
- Price
- CNSP $0.10
- PAVM $0.65
- Analyst Decision
- CNSP Strong Buy
- PAVM Strong Buy
- Analyst Count
- CNSP 1
- PAVM 1
- Target Price
- CNSP $0.50
- PAVM $19.00
- AVG Volume (30 Days)
- CNSP 30.2M
- PAVM 302.5K
- Earning Date
- CNSP 11-15-2024
- PAVM 11-14-2024
- Dividend Yield
- CNSP N/A
- PAVM N/A
- EPS Growth
- CNSP N/A
- PAVM N/A
- EPS
- CNSP N/A
- PAVM 0.53
- Revenue
- CNSP N/A
- PAVM $4,034,000.00
- Revenue This Year
- CNSP N/A
- PAVM $52.90
- Revenue Next Year
- CNSP N/A
- PAVM $248.84
- P/E Ratio
- CNSP N/A
- PAVM $1.23
- Revenue Growth
- CNSP N/A
- PAVM 166.27
- 52 Week Low
- CNSP $0.10
- PAVM $0.57
- 52 Week High
- CNSP $40.70
- PAVM $3.50
- Technical
- Relative Strength Index (RSI)
- CNSP 39.58
- PAVM 41.81
- Support Level
- CNSP $0.10
- PAVM $0.58
- Resistance Level
- CNSP $0.11
- PAVM $0.67
- Average True Range (ATR)
- CNSP 0.02
- PAVM 0.06
- MACD
- CNSP -0.00
- PAVM 0.02
- Stochastic Oscillator
- CNSP 3.02
- PAVM 38.89
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The Company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.